Off Patent
December 2027

Oracea

doxycycline

Galderma Laboratories LP

Capsule (oral) · NDA 050805

Last listed protection ends
December 19, 2027

The FDA lists 1 patent for Oracea, and this is the day the last one ends. It is not the date a generic goes on sale.

Patents and exclusivities

  1. Patent 7,749,532
    Claims the drug product and a use (U-1063)